At the recently concluded WHX Labs Kuala Lumpur 2025, B&E showcased its latest biochemical and hematology analyzers. The event, held from July 16th to 18th in Kuala Lumpur, Malaysia, gathered top medical device manufacturers and a large number of professional visitors from around the world.
By participating in WHX Labs Kuala Lumpur 2025, B&E not only demonstrated its competitiveness in the global market but also reaffirmed its commitment to continuous innovation and international market expansion. With the continuous introduction of new products, B&E remains dedicated to providing more comprehensive and advanced solutions for the global healthcare sector.
During the exhibition, B&E exhibited a range of products including the BC-200 biochemical analyzer, lumiSTAT A8, i-check200 handheld blood gas analyzer, Hemax60 hematology analyzer, CBS electrolyte analyzer, and G21 HbA1c analyzer.
BC-200 biochemical analyzer, which became a highlight of the show due to its integrated electrolyte module and superior performance, attracting significant attention from attendees. Meanwhile, the i-check200 handheld blood gas electrolyte analyzer received high praise for its convenience and immediate testing capabilities, making it highly suitable for emergency and intensive care environments.
Throughout the exhibition, B&E’s sales team provided detailed demonstrations and technical explanations, vividly showcasing the powerful functionalities of these instruments to visitors. Additionally, the company seized this valuable opportunity to engage in deep discussions with existing customers and potential partners, exploring industry trends and future collaboration possibilities.
Through its participation in WHX Labs Kuala Lumpur 2025, B&E has not only highlighted its competitive edge in the global market but also reinforced its determination for ongoing innovation and international market expansion. With a series of new products being launched, B&E is set to continue offering increasingly comprehensive and advanced solutions to the global healthcare community.